Vascularized Skin Equivalents
Vascularized Skin Equivalents - Related Videos
09:04
Generation of Self-assembled Vascularized Human Skin Equivalents
0 Views •
Cited by 11 •
2021
The goal of this protocol is to describe the generation and volumetric analysis of vascularized human skin equivalents using accessible and simple techniques for long term culture. To the extent possible, the rationale for steps is described to allow researchers the ability to customize based on their research needs.
08:35
Generation of a Three-dimensional Full Thickness Skin Equivalent and Automated Wounding
0 Views •
Cited by 53 •
2015
The goal of this protocol is to build up a three-dimensional full thickness skin equivalent, which resembles natural skin. With a specifically constructed automated wounding device, precise and reproducible wounds can be generated under maintenance of sterility.
07:56
A Full Skin Defect Model to Evaluate Vascularization of Biomaterials In Vivo
0 Views •
Cited by 13 •
2014
Vascularization is key to approaches in successful tissue engineering. Therefore, reliable technologies are required to evaluate the development of vascular networks in tissue-constructs. Here we present a simple and cost-effective method to visualize and quantify vascularization in vivo.
09:53
Whole-mount Immunohistochemical Analysis for Embryonic Limb Skin Vasculature: a Model System to Study Vascular Branching Morphogenesis in Embryo
0 Views •
Cited by 19 •
2011
We introduce a whole-mount immunohistochemistry and laser scanning confocal microscopy with multiple labelling for analyzing intricate vascular network formation in mouse embryonic limb skin.
01:26
Pharmaceutical Equivalents
0 Views •
2025
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
FAQs
The cell populations provide complementary roles within the construct. Keratinocytes contribute to the skin surface layer, fibroblasts support the underlying connective-tissue environment, and vascular cells form the vessel network. Combining these populations helps reproduce interactions between skin layers and microvessels rather than modeling each component in isolation, which is important for studying tissue behavior in a more physiologically relevant setting.
Endothelial cells are important because they organize into microvessels capable of supporting nutrient and oxygen transport through perfusion. This vascular function addresses a major limitation of skin models that lack an internal vessel network. It also provides a basis for evaluating whether engineered tissue can better maintain cell viability and support graft integration than an otherwise similar nonvascularized construct.
The biomaterial scaffold provides a three-dimensional environment in which skin and vascular cells can be arranged into a layered construct. Its role is therefore structural as well as biological: it supports the organization of keratinocytes, fibroblasts, and vascular cells while allowing the engineered tissue to reproduce features of native skin. This architecture improves the model's relevance for tissue and treatment studies.
Conventional skin models and grafts may reproduce skin tissue without reproducing its blood vessel network, whereas vascularized equivalents incorporate microvessels that support perfusion. That distinction matters because oxygen and nutrient transport are directly represented in the engineered construct. Consequently, vascularized systems can offer more relevant assessments of wound healing, vascularization, graft survival, and responses to drugs than models lacking this component.
Construction begins by combining keratinocytes, fibroblasts, and vascular cells within a biomaterial scaffold. The cells are arranged in a three-dimensional configuration that reproduces the layered organization of skin, while endothelial cells organize into microvessels. The resulting construct is then considered in relation to perfusion, since vessel formation is intended to support nutrient and oxygen transport throughout the engineered tissue.
Researchers can use these constructs when a study requires both skin architecture and vascular behavior. Supported applications include investigating wound healing, vascularization, skin disease, and drug responses. Their value comes from representing interactions between tissue layers and a perfused microvessel network, providing a platform that is more physiologically relevant than a skin model without vascular components.
For burns, chronic wounds, and tissue reconstruction, the engineered vessel network may help address the challenge of tissue integration and survival after grafting. The construct offers a way to study how vascularization relates to graft performance while also modeling skin structure. In regenerative medicine, this supports development and evaluation of substitutes intended to function more effectively within damaged tissue.
Vascularized skin equivalents provide a bioengineering platform for examining drug responses in a construct that includes layered skin and perfused microvessels. This broader tissue context can help researchers evaluate responses involving both skin cells and vascular components rather than relying only on isolated cell systems. Their use in personalized testing connects engineered tissue design with more individualized assessment of treatments.